Pacira BioSciences (PCRX) Stock Price & Financial Analysis
Pacira BioSciences Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Pacira BioSciences
What is the current stock price for PCRX?
As of the latest trading session, PCRX stock trades at $22.70. The 52-week range is $18.80–$27.64, with a day range of $22.18–$22.93.
What is the P/E ratio for PCRX?
Pacira BioSciences's trailing P/E ratio is 145.9, meaning investors pay $145.9 for every $1 of annual earnings. Pacira BioSciences operates in the Healthcare sector.
Does PCRX pay dividends?
Pacira BioSciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for PCRX?
Based on 3 analysts, the consensus for PCRX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of PCRX?
Pacira BioSciences's market capitalization is $1.02B, classifying it as a small-cap company. Pacira BioSciences operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.